-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Legend Biotech, Lowers Price Target to $33

Benzinga·10/09/2026 20:01:05
Listen to the news
JP Morgan analyst Jessica Fye maintains Legend Biotech (NASDAQ:LEGN) with a Neutral and lowers the price target from $35 to $33.